"Uncertainty looms over future of abortion pill access in the US"

A federal appeals court in the US has expressed skepticism about the government's decision to loosen regulations on mifepristone, a key abortion medication, and appeared to be prepared to limit access to it. The judges questioned why the FDA allowed the drug to be prescribed by medical professionals other than doctors and sent directly to patients by mail. The lawsuit was brought by antiabortion doctors and others who argued that the FDA improperly cleared the medication for use in 2000 and later removed safeguards to expand access to the pill. The legal battle over abortion medication has intensified in the months since the Supreme Court overturned Roe v. Wade's constitutional right to abortion.